ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,954.50
1.59%
Dow Jones
43,840.91
1.39%
US Dollar vs MXN
20.55
0.02%
Brent Oil
73.045
0.00%
Bitcoin
92,816.79
7.88%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Cotización

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
8.62
0.00
(0.00%)
Cerrado 02 Marzo 3:00PM
Delayed by 15 minutes
8.62
0.00
(0.00%)
Fuera de horario: 6:56PM
Delayed by 15 minutes
Gráfico avanzado

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
8.62
Postura de Compra
8.20
Postura de Venta
9.51
Volume Operado de la Acción
285,599
8.12 Rango del Día 8.66
5.46 Rango de 52 semanas 10.065
Capitalización de Mercado [m]
340.386M
Precio Anterior
8.62
Precio de Apertura
8.44
Hora
4
@
8.31
Última hora de negociación
Volumen financiero
US$ 2,427,177
Precio Promedio Ponderado
8.4985
Volumen promedio (3 m)
316,751
Acciones en circulación
39,487,879
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.59
Beneficio por acción (BPA)
-1.54
turnover
68.68M
Beneficio neto
-60.84M

Acerca de Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
www.pulmonx.com
Sede
Wilmington, Delaware, USA
Fundado
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was US$8.62. Over the last year, Pulmonx shares have traded in a share price range of US$ 5.46 to US$ 10.065.

Pulmonx currently has 39,487,879 shares in issue. The market capitalisation of Pulmonx is US$340.39 million. Pulmonx has a price to earnings ratio (PE ratio) of -5.59.

LUNG Últimas noticias

Más noticias

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
25 Febrero 2025
LUNG (0.00%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
25 Febrero 2025
LUNG (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
24 Febrero 2025
LUNG (0.00%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
20 Febrero 2025
LUNG (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
19 Febrero 2025
LUNG (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
21 Enero 2025
LUNG (0.00%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
17 Enero 2025
LUNG (0.00%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.29-3.254769921448.919.358.295740578.90221501CS
42.9752.56637168145.659.375.574736818.02313398CS
122.3437.26114649686.289.375.573167517.24262978CS
261.1114.78029294277.519.375.572662337.17669259CS
52-1.35-13.54062186569.9710.0655.463629167.63507617CS
156-16.6-65.82077716125.2228.34.0739038711.56964364CS
260-29.38-77.31578947373869.47794.0737560120.20761072CS

LUNG - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Pulmonx?
El precio actual de las acciones de Pulmonx es US$ 8.62
¿Cuántas acciones de Pulmonx están en circulación?
Pulmonx tiene 39,487,879 acciones en circulación
¿Cuál es la capitalización de mercado de Pulmonx?
La capitalización de mercado de Pulmonx es USD 340.39M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Pulmonx?
Pulmonx ha negociado en un rango de US$ 5.46 a US$ 10.065 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Pulmonx?
El ratio precio/beneficio de Pulmonx es -5.59
¿Cuál es el ratio de efectivo a ventas de Pulmonx?
El ratio de efectivo a ventas de Pulmonx es 4.96
¿Cuál es la moneda de reporte de Pulmonx?
Pulmonx presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Pulmonx?
El último ingresos anual de Pulmonx es USD 68.68M
¿Cuál es el último beneficio anual de Pulmonx?
El último beneficio anual de Pulmonx es USD -60.84M
¿Cuál es la dirección registrada de Pulmonx?
La dirección registrada de Pulmonx es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Pulmonx?
La dirección del sitio web de Pulmonx es www.pulmonx.com
¿En qué sector industrial opera Pulmonx?
Pulmonx opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STAKSTAK Inc
US$ 3.97
(156.13%)
174.23k
ORGOOrganogenesis Holdings Inc
US$ 6.21
(102.28%)
59M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
ARBBARB IOT Group Ltd
US$ 0.6635
(38.23%)
59.08M
NVNINVNI Group Ltd
US$ 0.99
(-50.50%)
72.79M
SPGCSacks Parente Golf Inc
US$ 0.2085
(-48.65%)
58.21M
ADGMAdagio Medical Holdings Inc
US$ 0.8081
(-47.53%)
756.76k
PRAXPraxis Precision Medicines Inc
US$ 38.60
(-40.64%)
3.2M
SAGSAG Holdings Ltd
US$ 1.19
(-38.97%)
789.86k
NVDANVIDIA Corporation
US$ 124.92
(3.97%)
389.48M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13.44
(7.78%)
154.46M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
LCIDLucid Group Inc
US$ 2.22
(-0.45%)
136.17M

LUNG Finanzas

Finanzas

Discusión

Ver feed completo
cadillacdave cadillacdave 2 minutos hace
Just don't tell L4BC there is nothing of any value here. He is clutching his Bowie NFT tightly in his hand. 😱
WDDD
nyt nyt 3 minutos hace
You want derision? No problem. You don't know what you're talking about because this had zero to do with your myopic view of the points being made. And that is.....it was not simple calling out of spelling or grammar. In this case, the import was that by failing to properly punctuate or use grammati
VPLM
Carjockey2 Carjockey2 3 minutos hace
More quality time with the family I see.

$HMBL

At least you made time for calzone Friday night with the wife..

Cheersp
HMBL
Eli-316 Eli-316 4 minutos hace
Can't wait for the day that we can say "UP HUGH" about ART Digital aka, CGAC!
CGAC
HGilS HGilS 4 minutos hace
See you in Vegas at $8!!!
ELTP
Truenorth2016 Truenorth2016 5 minutos hace
".I Post Pristine Verified Stock DD" ...Keep it up that was a huge nugget!!!
GCAN
ColdDarkHole ColdDarkHole 5 minutos hace
Why are you stuck on that phrase? Next year if we are still sitting here under 5$ you will still be saying that
NB
Truenorth2016 Truenorth2016 5 minutos hace
So Samsung Director Robert (Bob) Escalle on GCAN CEO Merger Partner Team and People Calling GCAN CEO a scam as he continueto shake hands and land big deals in the background, LOLOLOL
GCAN
TenKay TenKay 6 minutos hace
It might now makes sense why 1.3 BILLION shares hit the unrestricted on the 26th…

Sell into the pump?
HMBL
Humbert Humbert 6 minutos hace
All it means is that someone made two accounts.

In truth, I've never seen a company with facts that are easier to verify on this website; Delex is the real deal, as everyone can plainly see.
BNCM
elks elks 7 minutos hace
Lets go George bring it. The bulls want to run for a month straight.
GVSI
jimr1717 jimr1717 7 minutos hace
>Newbies< IFUS DD ✅ >>, Marc Walther was found liable in a securities fraud lawsuit...

Complaint:
https://drive.google.com/file/d/1Wpk0lRCJaTOI3dmR_BeSNw6eWtnTt71s/view

Judgement: $397,744.50
https://drive.google.com/file/d/1nZjmmsmCwJlFwm9TR6NvokHH1H3K01u
HGYN IFUS
cadillacdave cadillacdave 7 minutos hace
I have been saying this for a while, in my opinion, (even before the price retraction) that the company may be a target for a buyout. Not that IONQ is marketing or positioning itself for such. It's just that they seem to be making all the right moves, break throughs in technology, acquisitions, part
AAPL IONQ NVDA
PEACHMAN PEACHMAN 8 minutos hace
Multiple interviews by IFUS CEO provide transparency and progress of IFUS

https://impactfusionbrands.com/interviews/

IFUS STRONG
IFUS
Semper Fi 88 Semper Fi 88 8 minutos hace
I agree it has sucked waiting but every once in awhile I think about the fact that if they did not do it no way would I have this chance of a lifetime to get a lot richer on basically zero money. My avg cost ended up being around a buck fifty a share and with one simple trade back in 2013 my effect
FNMA
Monroe1 Monroe1 9 minutos hace
Name on time NBRI has been late filing. Not with Leopold nor Jared.

Performance Overview: NBRI

Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is S&P 500
.
YTD Return
NBRI
25.00%
S
NBRI
Tiger Money Tiger Money 9 minutos hace
With todays news, we are headed back to over a $1
WKSP
srm4u srm4u 10 minutos hace
Bird Flu Déjà Vu from the COVID Playbook
February 28, 2025
STORY AT-A-GLANCE
Public health officials are responding to bird flu (H5N1) using strategies similar to COVID-19, including extensive PCR testing and fearmongering, leading to significant food supply disruptions and pric
srm4u srm4u 10 minutos hace
Peace President Who Wants To Prevent Third World War Arrested By Deep State

True Hero Of Humanity, the Peace President who wants to prevent World War 3, was arrested by the Deep State. Watch: pic.twitter.com/8azjF7Dqbj
— StopWorldControl.com (@davidjsorensen) February 26, 2025
PEACHMAN PEACHMAN 11 minutos hace
25 articles support, educate, and validate IFUS products

https://impactfusionbrands.com/knowledge-base/

IFUS STRONG
IFUS
Vexari Vexari 11 minutos hace
Unfortunately

They must experience it for themselves

Planting the bug in their proverbial ear

May hasten the process Let me tell you why you're here

Yo
TenKay TenKay 12 minutos hace
“Furthermore, at no point does Wayne indicate that his .01 pps prediction represents "fair value."“

fair value? Where on earth did I say that?

I was questioning his prediction…

“Price next Friday? I say above .01”

However, I see no one is
HMBL
PegnVA PegnVA 12 minutos hace
I think Belarus and North Korea voted with us against that resolution too. - Show me your friends and I'll tell you what you are.
k9narc k9narc 12 minutos hace
WOOF!!! 45 48 20 77

Su Consulta Reciente

NASDAQ
LUNG
Pulmonx
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios